Annual report pursuant to Section 13 and 15(d)

STATEMENTS OF MEMBERS' STOCKHOLDERS' EQUITY

v3.22.0.1
STATEMENTS OF MEMBERS' STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-in Capital
Members Interests
Nonvoting Common Stock
Members Interests
Voting Common Stock
Accumulated Deficit
Total
Balances, Beginning at Dec. 31, 2019     $ 12,601,201   $ (17,618,710) $ (5,017,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Membership conversion to voting interests     $ (12,601,201) $ 12,601,201    
Conversion of convertible promissory notes       2,673,800   2,673,800
Equity-based compensation expense       2,000,000   2,000,000
Conversion of convertible promissory notes upon corporate conversion       3,434,457   3,434,457
Equity payment of accrued salaries       536,880   536,880
Corporate conversion at initial public offering $ 483 $ 21,245,855   $ (21,246,338)    
Corporate conversion at initial public offering (shares) 4,832,494          
Issuance of common shares for IPO, net of costs $ 345 31,053,543       31,053,888
Issuance of common shares for IPO, net of costs (shares) 3,450,000          
Share-based compensation expense   5,429,518       5,429,518
Exercise of warrants $ 2 176,248       176,250
Exercise of warrants (in shares) 22,581          
Net loss         (10,346,395) (10,346,395)
Balances, Ending at Dec. 31, 2020 $ 830 57,905,164     (27,965,105) 29,940,889
Balances, Ending (in shares) at Dec. 31, 2020 8,305,075          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense   322,881       322,881
Exercise of warrants $ 3 197,559       197,562
Exercise of warrants (in shares) 25,315          
Net loss         (15,960,268) (15,960,268)
Balances, Ending at Dec. 31, 2021 $ 833 $ 58,425,604     $ (43,925,373) $ 14,501,064
Balances, Ending (in shares) at Dec. 31, 2021 8,330,390